233 related articles for article (PubMed ID: 324834)
1. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.
Ross SA; Brown JC; Dupré J
Diabetes; 1977 Jun; 26(6):525-9. PubMed ID: 324834
[TBL] [Abstract][Full Text] [Related]
2. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
Salera M; Giacomoni P; Pironi L; Cornia G; Capelli M; Marini A; Benfenati F; Miglioli M; Barbara L
J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154
[TBL] [Abstract][Full Text] [Related]
3. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects.
Ross SA; Dupre J
Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238
[TBL] [Abstract][Full Text] [Related]
4. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
Nakanome C; Akai H; Umezu M; Toyota T; Goto Y
Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
[TBL] [Abstract][Full Text] [Related]
5. Hypersecretion of gastric inhibitory polypeptide induced by glucose ingestion in diabetes mellitus.
Takemura J; Seino Y; Tsuda K; Seino S; Ikeda M; Sakurai H; Imura H
Endocrinol Jpn; 1981 Feb; 28(1):17-21. PubMed ID: 7250066
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
Krarup T; Madsbad S; Moody AJ
J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
[TBL] [Abstract][Full Text] [Related]
7. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
Crockett SE; Mazzaferri EL; Cataland S
Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
[TBL] [Abstract][Full Text] [Related]
8. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
Ebert R; Frerichs H; Creutzfeldt W
Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
[TBL] [Abstract][Full Text] [Related]
9. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
[TBL] [Abstract][Full Text] [Related]
10. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics.
Krarup T; Madsbad S; Moody AJ; Regeur L; Faber OK; Holst JJ; Sestoft L
J Clin Endocrinol Metab; 1983 Jun; 56(6):1306-12. PubMed ID: 6341393
[TBL] [Abstract][Full Text] [Related]
11. Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients.
Fukase N; Igarashi M; Takahashi H; Manaka H; Yamatani K; Daimon M; Tominaga M; Sasaki H
Diabet Med; 1993; 10(1):44-9. PubMed ID: 8435987
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes.
Creutzfeldt W; Talaulicar M; Ebert R; Willms B
Diabetes; 1980 Feb; 29(2):140-5. PubMed ID: 6986299
[TBL] [Abstract][Full Text] [Related]
13. Hypersecretion of gastric inhibitory polypeptide in nondiabetic children with cystic fibrosis.
Ross SA; Morrison D; McArthur RG
Pediatrics; 1981 Feb; 67(2):252-4. PubMed ID: 7017571
[TBL] [Abstract][Full Text] [Related]
14. The effect of unabsorbable carbohydrate on gut hormones. Modification of post-prandial GIP secretion by guar.
Morgan LM; Goulder TJ; Tsiolakis D; Marks V; Alberti KG
Diabetologia; 1979 Aug; 17(2):85-9. PubMed ID: 488570
[TBL] [Abstract][Full Text] [Related]
15. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell.
Shichiri M; Kawamori R; Abe H
Diabetes; 1979 Apr; 28(4):272-5. PubMed ID: 374171
[TBL] [Abstract][Full Text] [Related]
16. [The effect of calcium on the release of gastric inhibitory polypeptide (GIP) - with reference to the release of GIP in patients with hyperparathyroidism (author's transl)].
Nakanome C; Akai H; Umezu M; Toyota T; Goto Y; Furukawa Y; Sato T; Yumita S; Bloom SR
Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):98-109. PubMed ID: 7044844
[TBL] [Abstract][Full Text] [Related]
17. Gastric inhibitory polypeptide response to hyper- and hypoglycemia in insulin-dependent diabetics.
Reynolds C; Tronsgard N; Gibbons E; Blix PM; Rubenstein AH
J Clin Endocrinol Metab; 1979 Aug; 49(2):255-61. PubMed ID: 457845
[TBL] [Abstract][Full Text] [Related]
18. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
[TBL] [Abstract][Full Text] [Related]
19. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
20. [Negative feedback effect of insulin on the secretion of gastric inhibitory polypeptide (GIP) (author's transl)].
Nakayasu A; Kubota N
Nihon Shokakibyo Gakkai Zasshi; 1979 Dec; 76(12):2432-41. PubMed ID: 393872
[No Abstract] [Full Text] [Related]
[Next] [New Search]